Skip to content

comparison of clinical outcomes of phacoemulsification combined with deep sclerectomy versus phacoemulsification combined with trabeculectomy in patients with primary angle closure glaucoma, A randomized controlled clinical trial

comparison of clinical outcomes of phacoemulsification combined with deep sclerectomy versus phacoemulsification combined with trabeculectomy in patients with primary angle closure glaucoma, A randomized controlled clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20161218031450N7
Enrollment
60
Registered
2024-02-26
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gluocoma. Glaucoma

Interventions

Intervention 1: Intervention group: Deep sclerectomy surgery with cataract .In this group of patients, a surgeon with a glaucoma fellowship undergoes phacoemulsification surgery for the patients catar

Sponsors

Research Assistant of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Significant cataract with PACG (a closed angle on gonioscopy for at least 180 degrees of angle) Uncontrolled IOP despite maximal tolerable medication Controlled glaucoma with multiple eye drops and progression of disease in the visual fields

Exclusion criteria

Exclusion criteria: Open angle glaucoma Secondary angle closure glaucoma: NVG, uveitic glaucoma PACG with 360-degree PAS or having PAS at the site of DS surgery (superior)

Design outcomes

Primary

MeasureTime frame
Intraocular pressure. Timepoint: The first week, the first month, the third month, the sixth month and the twelfth month after the operation. Method of measurement: Using a slate lamp and a Goldman tonometer.;The patient's vision. Timepoint: Months 1, 3, 6, 12 after the operation. Method of measurement: Using the Snellen chart.;Peripheral visual field. Timepoint: 6 and 12 months after the operation. Method of measurement: Using perimeter.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Farhad Najafzadeh

Tabriz University of Medical Sciences

miladsheikhian007@gmail.com+98 41 3657 7336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026